Wanbury per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹17.36₹20.55₹9.32₹9.29−₹6.18
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹16.35₹19.49₹8.98₹9.18−₹6.18
₹41.34₹41.34₹18.09₹8.53−₹2.22
₹186.80₹186.11₹182.94₹175.80₹152.77
—₹9.02₹7.96₹1.23₹6.05
−₹7.88−₹7.88−₹7.00₹1.23₹6.05
—₹0.00₹0.00₹0.96₹0.00
3.53.53.33.33.3
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

WANBURY₹174.16

Wanbury Limited

· Pharma & Health
₹ CrorePeersAHCLANUHPHRBAJAJHCARETHEMISMEDZIMLABLINCOLNSIGACHIVALIANTLABMcap ₹609 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS-6.189.299.3220.5517.36
Diluted EPS-6.189.188.9819.4916.35
Book Value per Share-2.228.5318.0941.3441.34
Revenue per Share152.77175.80182.94186.11186.80
Cash Flow per Share6.051.237.969.02—
Free Cash Flow per Share6.051.23-7.00-7.88-7.88
Dividends per Share0.000.960.000.00—
Shares Outstanding (cr)3.33.33.33.53.5
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.